G-protein-coupled receptors (GPCRs) modulate cytoplasmic signaling in response to extracellular stimuli, and are important therapeutic targets in a wide range of diseases. Differential ligands binding to receptor promote different conformations of GPCR–G-protein complex, which can adopt diverse active states. Such ligand-directed biased agonism is now an important focus in drug discovery. Therefore, structure determination of GPCR–G-protein complexes in variable activation states is important to elucidate the mechanisms of signal transduction, and to facilitate drug discovery.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: